CL
GMAB icon

Choreo LLC’s Genmab GMAB Stock Holding History

Choreo LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Buy
24,930
+41
+0.2% +$1.09K 0.01% 816
2026
Q1 		$668K Sell
24,889
-216
-0.9% -$6.47K 0.01% 795
2025
Q4 		$791K Sell
25,105
-4,258
-15% -$133K 0.01% 704
2025
Q3 		$901K Buy
29,363
+3,569
+14% +$87K 0.01% 648
2025
Q2 		$533K Sell
25,794
-246
-0.9% -$5.05K 0.01% 862
2025
Q1 		$510K Buy
26,040
+4,226
+19% +$88.6K 0.01% 819
2024
Q4 		$453K Sell
21,814
-6,755
-24% -$148K 0.01% 957
2024
Q3 		$690K Sell
28,569
-2,631
-8% -$70.3K 0.01% 744
2024
Q2 		$776K Buy
+31,200
New +$885K 0.01% 619

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Choreo LLC's GMAB Position: Q2 2026 in Review

Choreo LLC increased its Genmab (GMAB) stake by 0.16% in Q2 2026, buying an estimated $1.09K and bringing the position to 24,930 shares worth $685K. The position accounts for 0.01% of the portfolio, ranked #816.

Choreo LLC first reported a position in GMAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $901K in Q3 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Choreo LLC held 24,930 shares of Genmab worth $685K as of Q2 2026.
  • Choreo LLC bought 41 Genmab shares in Q2 2026, an estimated $1.09K.
  • Genmab made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #816 holding.
  • Choreo LLC first reported a position in Genmab in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Genmab position peaked at $901K in Q3 2025.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.